Sourcing Acotiamide API in Pakistan: Morgan's Advanced Raw Material for Pharmaceutical Formulators

Sourcing Acotiamide API in Pakistan: Morgan's Advanced Raw Material for Pharmaceutical Formulators

Product Name: Acotiamide Hydrochloride Trihydrate (Active Pharmaceutical Ingredient)

Brand/Supplier: Morgan

Therapeutic Category: Acetylcholinesterase (AChE) inhibitors / Gastrointestinal Prokinetics

Indications: Functional Dyspepsia (FD), Postprandial Distress Syndrome (PDS)

Important Notice: This catalog page is strictly intended for pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and R&D laboratories. Acotiamide supplied by Morgan is a raw Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory research. It is not a finished prescription medicine for patient consumption.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview

Developing highly effective treatments for functional gastrointestinal disorders requires an active ingredient that targets the root neuromuscular pathways of the gut. Acotiamide is a first-in-class prokinetic Active Pharmaceutical Ingredient (API) engineered specifically to address upper gastrointestinal motility issues.

Pharmacologically, Acotiamide functions as a targeted, reversible acetylcholinesterase (AChE) inhibitor within the enteric nervous system. By actively preventing the breakdown of acetylcholine in the stomach, this API enhances gastric accommodation and accelerates gastric emptying.

In finished pharmaceutical dosage forms—typically formulated as a 100mg oral solid tablet—Acotiamide is indicated for the management of Functional Dyspepsia (FD). It has proven highly effective in treating Postprandial Distress Syndrome (PDS), addressing chronic patient symptoms such as early satiation, meal-induced fullness, and persistent upper abdominal bloating.

Unlike traditional proton pump inhibitors (PPIs) or antacids that merely alter gastric pH levels, Acotiamide provides formulation scientists with a distinct, neurological therapeutic mechanism for non-ulcer dyspepsia, making it a critical addition to modern gastroenterology portfolios.

Sourcing Acotiamide Pakistan for Local Manufacturing

Formulating next-generation gastrointestinal therapies requires a dependable, unbroken supply of high-purity active ingredients. For pharmaceutical plants operating in the region, relying on overseas suppliers for specialty APIs often introduces extended lead times, complex customs clearance procedures, and unpredictable logistical delays.

Procuring Acotiamide Pakistan directly through Morgan mitigates these complex supply chain risks. We are committed to providing local pharmaceutical manufacturers with commercial and pilot-scale quantities that meet rigorous international pharmacopeial standards, while perfectly aligning with domestic regulatory frameworks.

Partnering with Morgan for your raw material procurement offers distinct operational advantages:

• Regulatory & DRAP Support: Morgan provides the comprehensive documentation required for compliance, including the open parts of the Drug Master File (DMF), stability study data, and detailed impurity profiles. This accelerates your Drug Regulatory Authority of Pakistan (DRAP) registration and dossier submission processes.
• Supply Chain Continuity: Our localized inventory and logistics management significantly reduce the transit times associated with international freight. Morgan sources and supplies your commercial batch schedules and production timelines are maintained without costly interruptions.
• Batch-to-Batch Consistency: Quality Assurance (QA) demands absolute uniformity. Every shipment of Morgan’s Acotiamide API is accompanied by a stringent Certificate of Analysis (CoA). Consistent particle size distribution, moisture content, and chemical purity ensure highly predictable blending, granulation, and compression behavior on your manufacturing floor.

Technical Specifications for QA & R&D

For Quality Control (QC) analysts and R&D formulation scientists, the structural and chemical integrity of the API is the paramount concern. Morgan’s Acotiamide API is synthesized in state-of-the-art, GMP-compliant facilities, ensuring optimal chiral purity and strict control over residual solvents and heavy metals.

• Chemical Name: N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]1,3-thiazole-4-carboxamide hydrochloride trihydrate
• CAS Number: 773092-05-0 (Hydrochloride Trihydrate) / 185106-16-5 (Free Base)
• Appearance: White to off-white crystalline powder
• Molecular Weight: 541.06 g/mol (Hydrochloride Trihydrate)
• Assay / Purity (HPLC): ≥ 99.0%
• Moisture Content (Karl Fischer): 9.0% – 12.0% (Conforming strictly to the standard trihydrate structure)
• Solubility Profile: Detailed solubility parameters in standard organic solvents and aqueous buffers are provided in Morgan's technical data sheet to assist your team with precise pre-formulation and dissolution studies.

Manufacturing and Handling Guidelines

Acotiamide is a potent prokinetic and enzyme inhibitor. Facilities processing this API must adhere to standard occupational exposure and pharmaceutical handling protocols during dispensing, milling, and compounding.

• Storage Conditions: The API must be stored in well-closed, light-resistant containers. To maintain the chemical stability of the trihydrate structure, it must be kept in a cool, dry environment, strictly protected from excessive heat and extreme humidity fluctuations.
• Occupational Safety: Manufacturing personnel must wear appropriate Personal Protective Equipment (PPE). This includes N95-equivalent respirators or industrial dust masks, chemical-resistant nitrile gloves, and protective eyewear to prevent the inhalation of airborne particulates or dermal absorption during the formulation and tableting process.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.